clindamycin

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

1 headnote for clindamycin

- Clindamycin

416 documents for clindamycin

- A randomized, investigator-blinded trial to assess the antimicrobial efficacy of a benzoyl peroxide 5%/clindamycin phosphate 1% gel compared with a clindamycin phosphate 1.2%/tretinoin 0.025% gel in the topical treatment of acne vulgaris.
ABSTRACT Background: Combination products in which the individual components have different mechanisms of antimicrobial action have been shown in ma...
- Journal of Drugs in Dermatology
- Vol. 9 Nbr. 2, February 2010
- 21 CFR 520.447 - Clindamycin solution.
- Code of Federal Regulations - Title 21: Food and Drugs
- 21 CFR 520.446 - Clindamycin capsules and tablets.
- Code of Federal Regulations - Title 21: Food and Drugs

- Oral Dosage Form New Animal Drugs; Clindamycin,
- FR, January 24, 2008
- Rules
- Food and Drug Administration
- Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3 multicenter randomized double-blind active-and vehicle-controlled study.
ABSTRACT Background: Topical fixed-combination therapy containing 1 % clindamycin as 1.2% clindamycin phosphate (CLNP) and 3% benzoyl peroxide (BPO)...
- Journal of Drugs in Dermatology
- Vol. 10 Nbr. 12, December 2011
- Evidence-based review: fixed-combination therapy and topical retinoids in the treatment of acne.
..., tazarotene, benzoyl peroxide, clindamycin, or erythromycin. Forty-two studies from January 1...
- Journal of Drugs in Dermatology
- Vol. 10 Nbr. 6, June 2011
- The development and optimization of a fixed combination of clindamycin and benzoyl peroxide aqueous gel.
ABSTRACT Fixed combination products of clindamycin 1% (as 1.2% clindamycin phosphate) and benzoyl peroxide (BPO) 5% are commonly used in the treatme...
- Journal of Drugs in Dermatology
- Vol. 8 Nbr. 7, July 2009
- Comparison of clindamycin/benzoyl peroxide, tretinoin plus clindamycin, and the combination of clindamycin/benzoyl peroxide and tretinoin plus clindamycin in the treatment of acne vulgaris: a randomized, blinded study.
Abstract In the treatment of mild to moderate acne vulgaris, the combination of an antibiotic and benzoyl peroxide provides enhanced efficacy over t...
- Journal of Drugs in Dermatology
- Vol. 4 Nbr. 5, September 2005
- Comparing a novel solubilized benzoyl peroxide gel with benzoyl peroxide/clindamycin: final data from a multicenter, investigator-blind, randomized study.
ABSTRACT Introduction: A solubilized 5% BPO gel has been developed to enhance the bioavailability, follicular penetration, and efficacy of BPO. Me...
- Journal of Drugs in Dermatology
- Vol. 8 Nbr. 9, September 2009
- Tolerability of clindamycin/tretinoin gel vs. Tretinoin microsphere gel and adapalene gel.
ABSTRACT Background: Newer agents and formulations seek to improve the tolerability of topical retinoid therapy. Recently, a gel containing crystall...
- Journal of Drugs in Dermatology
- Vol. 8 Nbr. 4, April 2009